Back to search

Article

Dexmedetomidine impacts IDO1 and CHRM3 in breast cancer

2024-02-07

Abstract excerpt

<h4>Background: </h4> As the most invasive breast cancer (BrCa), triple-negative BrCa (TNBC) has the worst survival. The use of dexmedetomidine potentially affected BrCa surgery and dexmedetomidine was reported to have direct effects on TNBC cells. The objective of this study is to explore the mechanisms underlying the effect of dexmedetomidine on TNBC. Methods Dexmedetomidine targets were predicted using The Can...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b3ac525b-af9d-5c13-bb0d-8fe35aade7c9
DOI
10.21203/rs.3.rs-3934535/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dexmedetomidine impacts IDO1 and CHRM3 in breast cancerDOI 10.21203/rs.3.rs-3934535/v1
Select a neighboring publication to make it the new centre.